Literature DB >> 18812214

Multi-target strategy for Parkinsonian patients: the role of deep brain stimulation in the centromedian-parafascicularis complex.

Alessandro Stefani1, Antonella Peppe, Mariangela Pierantozzi, Salvatore Galati, Vincenzo Moschella, Paolo Stanzione, Paolo Mazzone.   

Abstract

The intra-laminar (IL) thalamic complex, composed of centromedian (CM) and parafascicular (Pf) nucleus, is a strategic crossroad for the activity of the basal ganglia and is recently regaining its position has a putative neurosurgical target for Parkinsonian syndromes. The multi-target approach we have encouraged since the late nineties has allowed the combined implantation of a standard target (the subthalamic nucleus-STN or the internal pallidus-GPi) plus an innovative one (CM/Pf) in well-identified Parkinson's disease (PD) patients; hence, it is possible to study, in the same PD patients, the specific target-mediated effects on different clinical signs. Here, we focus on the potential usefulness of implanting the CM/Pf complex when required in the management of contra-lateral tremor (resistant to standard deep brain stimulation-DBS - in STN - , n=2) and disabling involuntary movements, partially responsive to GPi-DBS (n=6). When considering global UPDRS scores, CM/Pf-DBS ameliorate extra-pyramidal symptoms but not as strongly as STN (or GPi) does. Yet, CM/Pf acts very powerfully on tremor and contributes to the long-term management of l-Dopa-induced involuntary movements. The lack of cognitive deficits and psychic impairment associated with the improvement of their quality of life, in our small cohort of CM/Pf implanted patients, reinforces the notion of CM/Pf as a safe and attractive area for surgical treatment of advanced PD, possibly affecting not only motor but also associative functions.

Entities:  

Mesh:

Year:  2008        PMID: 18812214     DOI: 10.1016/j.brainresbull.2008.08.007

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  29 in total

Review 1.  [Deep brain stimulation for Parkinson's disease].

Authors:  J Herzog; G Deuschl
Journal:  Nervenarzt       Date:  2010-06       Impact factor: 1.214

Review 2.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

3.  Extracerebellar role for Cerebellin1: modulation of dendritic spine density and synapses in striatal medium spiny neurons.

Authors:  S V Kusnoor; J Parris; E C Muly; J I Morgan; A Y Deutch
Journal:  J Comp Neurol       Date:  2010-07-01       Impact factor: 3.215

Review 4.  [Deep brain stimulation for movement disorders].

Authors:  F Steigerwald; J Volkmann
Journal:  Nervenarzt       Date:  2012-08       Impact factor: 1.214

5.  Transgenic mouse lines subdivide external segment of the globus pallidus (GPe) neurons and reveal distinct GPe output pathways.

Authors:  Kevin J Mastro; Rachel S Bouchard; Hiromi A K Holt; Aryn H Gittis
Journal:  J Neurosci       Date:  2014-02-05       Impact factor: 6.167

6.  Resting-state networks link invasive and noninvasive brain stimulation across diverse psychiatric and neurological diseases.

Authors:  Michael D Fox; Randy L Buckner; Hesheng Liu; M Mallar Chakravarty; Andres M Lozano; Alvaro Pascual-Leone
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

7.  A review of basal ganglia circuits and physiology: Application to deep brain stimulation.

Authors:  Robert S Eisinger; Stephanie Cernera; Aryn Gittis; Aysegul Gunduz; Michael S Okun
Journal:  Parkinsonism Relat Disord       Date:  2019-01-09       Impact factor: 4.891

Review 8.  Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality?

Authors:  Thomas Wichmann; Mahlon R DeLong
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

9.  Is the loss of thalamostriatal neurons protective in parkinsonism?

Authors:  Sheila V Kusnoor; E Chris Muly; James I Morgan; Ariel Y Deutch
Journal:  Parkinsonism Relat Disord       Date:  2009-12       Impact factor: 4.891

Review 10.  Surgical treatment of Parkinson's disease: patients, targets, devices, and approaches.

Authors:  Aparna Wagle Shukla; Michael Scott Okun
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.